Kiniksa Pharmaceuticals International (KNSA) Other Non-Current Assets (2021 - 2025)
Historic Other Non-Current Assets for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $8.3 million.
- Kiniksa Pharmaceuticals International's Other Non-Current Assets rose 553.93% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year increase of 553.93%. This contributed to the annual value of $10.3 million for FY2024, which is 114727.93% up from last year.
- According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Other Non-Current Assets is $8.3 million, which was up 553.93% from $8.2 million recorded in Q2 2025.
- Over the past 5 years, Kiniksa Pharmaceuticals International's Other Non-Current Assets peaked at $10.3 million during Q4 2024, and registered a low of $827000.0 during Q4 2023.
- Over the past 5 years, Kiniksa Pharmaceuticals International's median Other Non-Current Assets value was $5.8 million (recorded in 2022), while the average stood at $5.9 million.
- As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Other Non-Current Assets crashed by 8580.01% in 2023, and later skyrocketed by 114727.93% in 2024.
- Kiniksa Pharmaceuticals International's Other Non-Current Assets (Quarter) stood at $8.7 million in 2021, then crashed by 33.21% to $5.8 million in 2022, then crashed by 85.8% to $827000.0 in 2023, then soared by 1147.28% to $10.3 million in 2024, then dropped by 19.65% to $8.3 million in 2025.
- Its last three reported values are $8.3 million in Q3 2025, $8.2 million for Q2 2025, and $8.2 million during Q1 2025.